OMOZUWA OMIGIE: Open Payments
NPI 1679289730 · OVERLAND PARK, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,985 in 237 payments from 22 companies in 2025. Trend: 2023 $1,702 · 2024 $3,276 · 2025 $4,985
Food & beverage: $4,918Education: $67
| Company | Payments | Amount |
|---|---|---|
| Vanda Pharmaceuticals Inc. | 27 | $767 |
| ABBVIE INC. | 37 | $673 |
| Axsome Therapeutics, Inc. | 24 | $423 |
| Neurocrine BioSciences, Inc. | 13 | $336 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 17 | $311 |
| JAZZ PHARMACEUTICALS INC. | 11 | $286 |
| Teva Pharmaceuticals USA, Inc. | 10 | $261 |
| Otsuka America Pharmaceutical, Inc. | 12 | $242 |
| Bausch Health US, LLC | 9 | $206 |
| Noven Therapeutics, LLC | 11 | $171 |
Products named: HETLIOZ, VRAYLAR, Auvelity, REXULTI, INGREZZA, CAPLYTA, XYWAV, AUSTEDO XR.
Industry payments across KS — which companies pay providers there.
